Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes
This study examines the efficacy and safety of tirzepatide vs insulin lispro adjunctive therapy to insulin glargine among those receiving basal insulin with inadequately controlled type 2 diabetes.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research
More News: American Medical Association (AMA) | Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Humalog | Insulin | Lantus | Study